Literature DB >> 21150319

Proteomic profiling of Myc-associated proteins.

Pooja Agrawal1, Kebing Yu, Arthur R Salomon, John M Sedivy.   

Abstract

Mammalian c-Myc is a member of a small family of three closely related transcription factors. The Myc family of proto-oncogenes are among the most potent activators of tumorigenesis, and are frequently overexpressed in diverse cancers. c-Myc has an unusually broad array of regulatory functions, which include, in addition to roles in the cell cycle and apoptosis, effects on a variety of metabolic functions, cell differentiation, senescence, and stem cell maintenance. A significant number of c-Myc interacting proteins have already been defined, but it is widely believed that the c-Myc interactome is vastly larger than currently documented. In addition to interactions with components of the transcription machinery, transcription independent nuclear interactions with the DNA replication and RNA processing pathways have been reported. Cytoplasmic roles of c-Myc have also been recently substantiated. Recent advances in proteomics have opened new possibilities for the isolation of protein complexes under native conditions and confidently identifying the components using ultrasensitive, high mass accuracy and high resolution mass spectrometry techniques. In this communication we report a new tandem affinity purification (TAP) c-Myc interaction screen that employed new cell lines with near-physiological levels of c-Myc expression with multi-dimensional protein identification techniques (MudPIT) for the detection and quantification of proteins. Both label-free and the recently developed stable isotope labeling with amino acids in cell culture (SILAC) methodologies were used. Combined data from multiple biological replicates provided a dataset of 418 non-redundant proteins, 389 of which are putative novel interactors. This new information should significantly advance our understanding of this interesting and important master regulator.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21150319      PMCID: PMC3047814          DOI: 10.4161/cc.9.24.14199

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  45 in total

1.  A generic protein purification method for protein complex characterization and proteome exploration.

Authors:  G Rigaut; A Shevchenko; B Rutz; M Wilm; M Mann; B Séraphin
Journal:  Nat Biotechnol       Date:  1999-10       Impact factor: 54.908

2.  Automated immobilized metal affinity chromatography/nano-liquid chromatography/electrospray ionization mass spectrometry platform for profiling protein phosphorylation sites.

Authors:  Scott B Ficarro; Arthur R Salomon; Laurence M Brill; Daniel E Mason; Michelle Stettler-Gill; Ansgar Brock; Eric C Peters
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

3.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry.

Authors:  Joshua E Elias; Steven P Gygi
Journal:  Nat Methods       Date:  2007-03       Impact factor: 28.547

4.  Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex.

Authors:  Penggao Dai; Wen C Xiong; Lin Mei
Journal:  J Biol Chem       Date:  2005-11-21       Impact factor: 5.157

5.  Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription.

Authors:  Francesco Faiola; Xiaohui Liu; Szuying Lo; Songqin Pan; Kangling Zhang; Elena Lymar; Anthony Farina; Ernest Martinez
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 6.  Cancer therapeutics: targeting the dark side of Myc.

Authors:  Romina Ponzielli; Sigal Katz; Dalia Barsyte-Lovejoy; Linda Z Penn
Journal:  Eur J Cancer       Date:  2005-10-20       Impact factor: 9.162

7.  Interaction partners of the PDZ domain of erbin.

Authors:  Angelika Ress; Karin Moelling
Journal:  Protein Pept Lett       Date:  2006       Impact factor: 1.890

8.  Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation.

Authors:  Sabine Zöchbauer-Müller; Kwun M Fong; Joseph Geradts; Xie Xu; Sonja Seidl; Adelheid End-Pfützenreuter; György Lang; Gerwin Heller; Christoph C Zielinski; Adi F Gazdar; John D Minna
Journal:  Oncogene       Date:  2005-09-15       Impact factor: 9.867

9.  Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach.

Authors:  Heike B Koch; Ru Zhang; Berlinda Verdoodt; Aaron Bailey; Chang-Dong Zhang; John R Yates; Antje Menssen; Heiko Hermeking
Journal:  Cell Cycle       Date:  2007-01-20       Impact factor: 4.534

Review 10.  Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation.

Authors:  Z Nagy; L Tora
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

View more
  32 in total

1.  AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay.

Authors:  Xiulei Mo; Qi Qi; Andrei A Ivanov; Qiankun Niu; Yin Luo; Jonathan Havel; Russell Goetze; Sydney Bell; Carlos S Moreno; Lee A D Cooper; Margaret A Johns; Fadlo R Khuri; Yuhong Du; Haian Fu
Journal:  Mol Pharmacol       Date:  2017-01-13       Impact factor: 4.436

2.  Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters.

Authors:  Chui-Sun Yap; Abigail L Peterson; Gastone Castellani; John M Sedivy; Nicola Neretti
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

3.  Myc orchestrates a regulatory network required for the establishment and maintenance of pluripotency.

Authors:  Keriayn N Smith; Jae-Min Lim; Lance Wells; Stephen Dalton
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

Review 4.  MYC cofactors: molecular switches controlling diverse biological outcomes.

Authors:  Stephen R Hann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

5.  Controlling for gene expression changes in transcription factor protein networks.

Authors:  Charles A S Banks; Zachary T Lee; Gina Boanca; Mahadevan Lakshminarasimhan; Brad D Groppe; Zhihui Wen; Gaye L Hattem; Chris W Seidel; Laurence Florens; Michael P Washburn
Journal:  Mol Cell Proteomics       Date:  2014-04-10       Impact factor: 5.911

6.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

7.  Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.

Authors:  Amy S Farrell; Carl Pelz; Xiaoyan Wang; Colin J Daniel; Zhiping Wang; Yulong Su; Mahnaz Janghorban; Xiaoli Zhang; Charlie Morgan; Soren Impey; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

8.  ZEB1 drives epithelial-to-mesenchymal transition in lung cancer.

Authors:  Jill E Larsen; Vaishnavi Nathan; Jihan K Osborne; Rebecca K Farrow; Dhruba Deb; James P Sullivan; Patrick D Dospoy; Alexander Augustyn; Suzie K Hight; Mitsuo Sato; Luc Girard; Carmen Behrens; Ignacio I Wistuba; Adi F Gazdar; Nicholas K Hayward; John D Minna
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

9.  Transcription factors with conserved binding sites near ATOH1 on the POU4F3 gene enhance the induction of cochlear hair cells.

Authors:  Ryoukichi Ikeda; Kwang Pak; Eduardo Chavez; Allen F Ryan
Journal:  Mol Neurobiol       Date:  2015-04       Impact factor: 5.590

10.  Myc binds the pluripotency factor Utf1 through the basic-helix-loop-helix leucine zipper domain.

Authors:  Agnieszka I Laskowski; Paul S Knoepfler
Journal:  Biochem Biophys Res Commun       Date:  2013-05-09       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.